If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Friday broker round-up

Fri, 13th Apr 2012 10:09
Aggreko: UBS ups target from 2,500p to 2,550p, buy rating unchanged.AstraZeneca: Jefferies maintains hold with a 3,050p target.Burberry UBS lifts target from 1,370p to 1,580p, neutral recommendation maintained.Chariot Oil & Gas: Merchant Securities initiates coverage with a buy rating and 402.1p target.Daily Mail & General Trust: Investec maintains buy rating and 578p target.Euromoney Institutional Investor: Investec reiterates buy recommendation and 799p target.Logica: Investec maintains sell recommendation. Rolls-Royce: Jefferies raises target from 815p to 950p, buy rating kept.Sage: Jefferies downgrades from buy to hold, target cut from 345p to 320p.BC Burberry Astrazeneca Sage Group Rolls-Royce Chariot

Shares in this article

Related News

Hutchmed drug approved in China for advanced gastric cancer
2 hours ago

Hutchmed drug approved in China for advanced gastric cancer

(Alliance News) - Hutchmed China Ltd on Thursday announced regulatory approval for savolitinib, brand name 'ORPATHYS', for a form of gastric cancer wi...

Pharmaceuticals Hutchmed + 1 more share
AstraZeneca signs CSPC China deal for experimental kidney disease drugs
5 hours ago

AstraZeneca signs CSPC China deal for experimental kidney disease drugs

July 2 (Reuters) - AstraZeneca ​has entered into a deal worth up to $1.77 billion ​with ‌CSPC Pharmaceutical Group to discover and develop experimenta...

WINNERS & LOSERS: PPHE Hotel ends sales process; CMC Markets rises
6 hours ago

WINNERS & LOSERS: PPHE Hotel ends sales process; CMC Markets rises

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday.